f2f086789a1003af000a871ffd83a96331e29df9
BCR.pdf
| ... | ... | Binary files a/BCR.pdf and /dev/null differ |
HNRNPH1.md
| ... | ... | @@ -1,6 +1,6 @@ |
| 1 | 1 | # HNRNPH1 |
| 2 | 2 | ## Overview |
| 3 | -Mutations in HNRNPH1 are enriched at splicing signals in exon 4. These result in deregulated splicing and increased expression of the hnRNP H1 protein. This overexpression is linked to enhanced cell proliferation and survival, contributing to the aggressive nature of MCL. <sup>1,2</sup> Although initially characterized in MCL, the same pattern of mutations appears in a small number of DLBCLs. |
|
| 3 | +Non-coding mutations, including synonymous and intronic mutations, are enriched at splicing signals in exon 4 of HNRNPH1. These result in deregulated splicing and increased expression of the hnRNP H1 protein. This overexpression is linked to enhanced cell proliferation and survival, contributing to the aggressive nature of MCL. <sup>1,2</sup> Although initially characterized in MCL, the same pattern of mutations appears in a small number of DLBCLs. |
|
| 4 | 4 | |
| 5 | 5 | ## Relevance tier by entity |
| 6 | 6 | |
| ... | ... | @@ -27,10 +27,6 @@ Mutations in HNRNPH1 are enriched at splicing signals in exon 4. These result in |
| 27 | 27 | |DLBCL |No |No |2.337 |10.139 | |
| 28 | 28 | |FL |No |No |0.000 | 0.000 | |
| 29 | 29 | |
| 30 | - |
|
| 31 | -> [!NOTE] |
|
| 32 | -> First described in MCL in 2020 by [Pararajalingam P](https://pubmed.ncbi.nlm.nih.gov/32160292) |
|
| 33 | - |
|
| 34 | 30 | ## HNRNPH1 Hotspots |
| 35 | 31 | |
| 36 | 32 | | Chromosome |Coordinate (hg19) | ref>alt | HGVSp | |
| ... | ... | @@ -45,8 +41,12 @@ View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/H |
| 45 | 41 | |
| 46 | 42 |  |
| 47 | 43 | |
| 44 | +## HNRNPH1 Expression |
|
| 45 | + |
|
| 46 | + |
|
| 47 | + |
|
| 48 | 48 | ## References |
| 49 | 49 | 1. *Pararajalingam, P., Coyle, K., Arthur, S., Thomas, N., Alcaide, M., Meissner, B., Boyle, M., Qureshi, Q., Grande, B., Rushton, C., Slack, G., Mungall, A., Tam, C., Agarwal, R., Dawson, S., Lenz, G., Balasubramanian, S., Gascoyne, R., Steidl, C., Connors, J., Villa, D., Audas, T., Marra, M., Johnson, N., Scott, D., & Morin, R. (2020). Coding and non-coding drivers of mantle cell lymphoma identified through exome and genome sequencing.. Blood. https://doi.org/10.1182/blood.2019002385.* |
| 50 | 50 | 2. *Coyle, K., Qureshi, Q., Pararajalingam, P., Thomas, N., Audas, T., & Morin, R. (2020). Perturbations in HNRNPH1 Splicing and Abundance Affect Global Splicing and Proliferation in Mantle Cell Lymphoma. Blood, 136, 23-24. https://doi.org/10.1182/BLOOD-2020-141389.* |
| 51 | -## HNRNPH1 Expression |
|
| 52 | - |
|
| 51 | + |
|
| 52 | +<!-- NONCODING --> |
HNRNPU.md
| ... | ... | @@ -1,61 +0,0 @@ |
| 1 | -# HNRNPU |
|
| 2 | -## Overview |
|
| 3 | -HNRNPU is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus. Mutations in HNRNPU are haploinsufficient and significantly alter the transcriptome of MYC-driven lymphomas. These mutations were found in a notable percentage of high-grade B-cell lymphomas with double-hit BCL2 translocations (HGBL-DH-BCL2) and Burkitt lymphoma (BL).<sup>1</sup> |
|
| 4 | - |
|
| 5 | -## Relevance tier by entity |
|
| 6 | - |
|
| 7 | -|Entity|Tier|Description | |
|
| 8 | -|:------:|:----:|--------------------------| |
|
| 9 | -|BL |1-a | aSHM target and high-confidence BL gene | |
|
| 10 | -|DLBCL |1-a | aSHM target and high-confidence DLBCL gene| |
|
| 11 | - |
|
| 12 | -## Mutation incidence in large patient cohorts (GAMBL reanalysis) |
|
| 13 | - |
|
| 14 | -|Entity|source |frequency (%)| |
|
| 15 | -|:------:|:---------------------:|:-------------:| |
|
| 16 | -|BL |GAMBL genomes+capture|5.77 | |
|
| 17 | -|BL |Thomas cohort |6.40 | |
|
| 18 | -|BL |Panea cohort |8.90 | |
|
| 19 | -|DLBCL |GAMBL genomes |2.49 | |
|
| 20 | -|DLBCL |Schmitz cohort |3.40 | |
|
| 21 | -|DLBCL |Reddy cohort |2.40 | |
|
| 22 | -|DLBCL |Chapuy cohort |3.42 | |
|
| 23 | - |
|
| 24 | -## Mutation pattern and selective pressure estimates |
|
| 25 | - |
|
| 26 | -|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)| |
|
| 27 | -|:------:|:----:|:---------------------:|:----------------:|:----------------:| |
|
| 28 | -|BL |Yes |Yes |1.081 |27.052 | |
|
| 29 | -|DLBCL |Yes |No |1.712 | 0.000 | |
|
| 30 | -|FL |Yes |No |4.865 |31.056 | |
|
| 31 | - |
|
| 32 | -## aSHM regions |
|
| 33 | - |
|
| 34 | -|chr_name|hg19_start|hg19_end |region |regulatory_comment| |
|
| 35 | -|:--------:|:----------:|:---------:|:-------------------------------------------------------------------------------------------:|:------------------:| |
|
| 36 | -|chr1 |245023502 |245029083|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr1%3A245023502%2D245029083)|NA | |
|
| 37 | - |
|
| 38 | -> [!NOTE] |
|
| 39 | -> First described in BL in 2019 by [Panea RI](https://pubmed.ncbi.nlm.nih.gov/31558468) |
|
| 40 | - |
|
| 41 | - |
|
| 42 | - ## HNRNPU Hotspots |
|
| 43 | - |
|
| 44 | -| Chromosome |Coordinate (hg19) | ref>alt | HGVSp | |
|
| 45 | - | :---:| :---: | :--: | :---: | |
|
| 46 | -| chr1 | 245027102 | G>A | Q170* | |
|
| 47 | -| chr1 | 245027099 | G>C | Q171E | |
|
| 48 | -| chr1 | 245027099 | G>A | Q171* | |
|
| 49 | - |
|
| 50 | -View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/HNRNPU_protein.html) or [hg38](https://morinlab.github.io/LLMPP/GAMBL/HNRNPU_protein_hg38.html) |
|
| 51 | - |
|
| 52 | - |
|
| 53 | - |
|
| 54 | -View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/HNRNPU.html) or [hg38](https://morinlab.github.io/LLMPP/GAMBL/HNRNPU_hg38.html) |
|
| 55 | - |
|
| 56 | - |
|
| 57 | - |
|
| 58 | -## References |
|
| 59 | -1. *Qureshi, Q., Coyle, K., Thomas, N., Collinge, B., Dreval, K., Hilton, L., Wong, J., Scott, D., Audas, T., & Morin, R. (2023). Hnrnpu mutations Are Haploinsufficient and Alter the Transcriptome of MYC-Driven Lymphomas. Blood. https://doi.org/10.1182/blood-2023-190409.* |
|
| 60 | -## HNRNPU Expression |
|
| 61 | - |
NFKBIZ.md
| ... | ... | @@ -40,8 +40,11 @@ View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAM |
| 40 | 40 | View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/NFKBIZ.html) or [hg38](https://morinlab.github.io/LLMPP/GAMBL/NFKBIZ_hg38.html) |
| 41 | 41 | |
| 42 | 42 |  |
| 43 | + |
|
| 43 | 44 | ## NFKBIZ Expression |
| 44 | 45 |  |
| 45 | 46 | |
| 46 | 47 | ## References |
| 47 | 48 | 1. *Arthur SE, Jiang A, Grande BM, Alcaide M, Cojocaru R, Rushton CK, Mottok A, Hilton LK, Lat PK, Zhao EY, Culibrk L, Ennishi D, Jessa S, Chong L, Thomas N, Pararajalingam P, Meissner B, Boyle M, Davidson J, Bushell KR, Lai D, Farinha P, Slack GW, Morin GB, Shah S, Sen D, Jones SJM, Mungall AJ, Gascoyne RD, Audas TE, Unrau P, Marra MA, Connors JM, Steidl C, Scott DW, Morin RD. Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma. Nat Commun. 2018 Oct 1;9(1):4001. doi: 10.1038/s41467-018-06354-3. PMID: 30275490; PMCID: PMC6167379.* |
| 49 | + |
|
| 50 | +<!-- NONCODING --> |
NFKBIZ.pdf
| ... | ... | Binary files a/NFKBIZ.pdf and /dev/null differ |